Covid-19: Beginning 2021, India to produce 100 million doses of Russia’s Sputnik V vaccine
New Delhi, Nov 27: Russian Direct Investment Fund (RDIF) and pharma firm Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine against COVID-19, Russia's sovereign wealth fund said in a statement.
The parties intend to start the production of Sputnik V in the beginning of 2021, it added.
Recommended Video
Oxford Astra Zeneca's vaccine error | What happens to India trials? | Oneindia News
Currently Phase III clinical trials are approved and are ongoing in Belarus, the UAE, Venezuela and other countries. Phase II-III trials are taking place in India, RDIF said.
More From
-
Dhurandhar 2 Box Office Collection Day 7: Ranveer Singh's Film Dominates, Inches Closer to ₹1000 Crore Club -
‘Not a Dalal Nation’: S Jaishankar Hits Back at Pak Mediation Narrative on US-Iran Crisis -
Bangalore Gold Silver Rate Today, 25 March 2026: Gold, Silver Prices Rise After Extended Losses -
Ananya Birla in Spotlight After RCB Owner Deal; Fans Draw Parallels with Kavya Maran -
Gas Cylinder Booking Rules Changed to 35 Days? Truth Behind Viral Claims -
Platinum Rate Today, 25 March 2026: Rising Platinum Prices Strengthen Its Position Against Gold -
Mamata Banerjee Resigns from 23 Posts Ahead Of Bengal Elections, Bhawanipur Battle Takes Centre Stage -
Ram Navami 2026 On March 26 Or 27? Know Exact Date, Madhyahna Muhurat, Tithi Timings And Puja Rituals -
Majority in US Call Iran Military Moves ‘Excessive’ Amid Fuel Price Fears -
‘Iran Has Agreed To Never Pursue Nuclear Weapons’: Donald Trump Declares Victory After Three-Week War -
Congress Leader Sonia Gandhi Admitted To Sir Ganga Ram Hospital, Doctors Say She Is Stable -
From Cricketer To Chairman: RCB Sold For Rs 16,000 Crore, Aryaman Birla Takes Charge- Who Is He?
Click it and Unblock the Notifications
Sign in with Google